Last edited by Grom
Sunday, July 12, 2020 | History

1 edition of High-Risk IV Medications in Special Patient Populations found in the catalog.

High-Risk IV Medications in Special Patient Populations

Sandra Kane-Gill

High-Risk IV Medications in Special Patient Populations

by Sandra Kane-Gill

  • 25 Want to read
  • 8 Currently reading

Published by Springer-Verlag London Limited in London .
Written in English

    Subjects:
  • Internal medicine,
  • Emergency medicine,
  • Medicine,
  • Critical care medicine,
  • Anesthesiology,
  • Pharmacy

  • Edition Notes

    Statementedited by Sandra Kane-Gill, Joseph Dasta
    ContributionsDasta, Joseph, SpringerLink (Online service)
    The Physical Object
    Format[electronic resource] /
    ID Numbers
    Open LibraryOL25545207M
    ISBN 109780857296054, 9780857296061

    CMS High Risk Medication List for Elderly. Quality ID # (NQF ): Use of High-Risk Medications in the Elderly – National Quality Strategy Domain: Patient Safety – Meaningful Measure Area: Medication Management.   CHAPTER 21 Special Considerations for the Administration of Medications to the Elderly LEARNING OBJECTIVES On completion of the materials provided in this chapter, you will be able to: 1 Understand the implications of the physiological changes of aging and their effect on medication administration to the elderly 2 Understand the special problems and issues related to medication.

    Identify different drugs using the Drug ID field located in the NDC list on NCQA’s Web site (). NCQA provided a comprehensive list of medications and NDC codes to on Novem Please see the Excel file Table DAE-A - Use of High-Risk Medications in the Elderly (DAE).xls for the list of NDCs to use. A.   Introduction. Drug use and injection drug use are important factors in the epidemiology of tuberculosis (TB) in developed and developing countries[1–8].While the incidence of TB in most industrialized nations has declined over the past decade, the burden of disease is being increasingly borne by urban sub-populations, including drug users.

      Background and Rationale. Pharmacotherapy is central to the medical care of persons above the age of 65, and this population consumes more than 30 percent of all prescriptions. 1 Of these patients, approximately 50 percent take 5 or more medications, and 12 percent take at least 10 medications regularly. 2 The pervasiveness of therapeutic drug use in community-dwelling elderly . al to December Study Selection: Based on three key components: 1) environment and patients, 2) the medication use process, and 3) the patient safety surveillance system. The committee collectively developed Population, Intervention, Comparator, Outcome questions and quality of evidence statements pertaining to medication errors and adverse drug events addressing the key components. A.


Share this book
You might also like
history of the Halifax Permanent Benefit Building Society, being a Jubilee Memorial of this society.

history of the Halifax Permanent Benefit Building Society, being a Jubilee Memorial of this society.

Intrasentential pronominalization and functional sentence perspective (in Czech, Russian, and English)

Intrasentential pronominalization and functional sentence perspective (in Czech, Russian, and English)

Protomycetaceae of Switzerland

Protomycetaceae of Switzerland

Grande finale.

Grande finale.

Archaeology and the origins of philosophy

Archaeology and the origins of philosophy

The Orchard mason bee (Osmia lignaria propinqua Cresson)

The Orchard mason bee (Osmia lignaria propinqua Cresson)

The effects of new ways of working on employees stress levels

The effects of new ways of working on employees stress levels

On the Polar Star in the Arctic Sea

On the Polar Star in the Arctic Sea

Lost love

Lost love

High-Risk IV Medications in Special Patient Populations by Sandra Kane-Gill Download PDF EPUB FB2

“This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. It is intended for clinicians treating critically ill patients with high-risk intravenous medications.

A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of.

Book Review: High-Risk IV Medications in Special Patient Populations. High-Risk IV Medications in Special Patient Populations. Annals of PharmacotherapyShare.

Share. Social Media; High-Risk IV Medications in Special Patient Populations Show all authors. First Published June   Read "High-Risk IV Medications in Special Patient Populations" by available from Rakuten Kobo. Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medicati Brand: Springer London.

High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications.

Medical Books Free This Website Is Intended To Provide Medical Ebooks For Free Download By Doctors & Medical Students CLICK HERE FOR MEDICAL BOOKS FREE DOWNLOAD FOR THOSE MEMBERS WITH BLOCKED DOWNLOAD LINKS.

High-Risk IV Medications in Special Patient Populations PDF Free Download E-BOOK DESCRIPTION Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients.

High-Risk IV Medications in Special Patient Populations PDF Author Sandra Kane-Gill File size MB Year Pages Language English File format PDF Category Free Medical Books Download the Book Download Book Description: Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations.

High-Risk IV Medications in Special Patient Populations Content Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients.

From the reviews:"This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. It is intended for clinicians treating critically ill patients with high-risk intravenous medications.

Specific Medications; EPINEPHrine, IM, subcutaneous: epoprostenol (e.g., Flolan), IV: insulin U (special emphasis*) (* All forms of insulin, subcutaneous and IV, are considered a class of high-alert medications.

Insulin U has been singled out for special emphasis to bring attention to the need for distinct strategies to prevent the types of errors that occur with this concentrated form.

High-Risk IV Medications in Special Patient Populations by Sandra Kane-Gill and Publisher Springer. Save up to 80% by choosing the eTextbook option for ISBN:X. The print version of this textbook is ISBN:High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring.

Search Tips. Phrase Searching You can use double quotes to search for a series of words in a particular order. For example, "World war II" (with quotes) will give more precise results than World war II (without quotes). Wildcard Searching If you want to search for multiple variations of a word, you can substitute a special symbol (called a "wildcard") for one or more letters.

high-risk IV drug concentrations and dosage units significantly reduces variability in IV therapy, helping to promote safer and more consistent practices in administering high-risk IV medications to patients. Potential Benefits • Improved patient safety due to reduced complexity, variability, and opportunities for high-risk IV medication errors.

high-risk IV medications limit settings for adult patients in intensive and acute care units. Intended Audience The document is intended for clinical leaders involved in caring for adult intensive care and acute care patients.

Be able to identify what a high alert medication is and what medications are considered high alert at Nebraska Medicine (NM) 2. Identify best practice recommendations and organizational safeguards used to reduce risk with high alert medications 3. Understand how to safely evaluate, order and monitor high risk medications 4.

High-Risk IV Medications Intra- and Inter-Hospital Standardization: Drug Concentrations and Dosage Units How-to Guide As part of continuing eff orts to improve patient and medication safety, in January members of the San Diego Patient Safety Consortium (SDPSC) evaluated areas for local patient safety improvements.

medications to the smallest and most fragile patient populations are at the forefront of concerns for bedside practitioners in the NICU setting.

Healthcare providers need to ensure that drug therapy achieves maximum benefits and avoids therapeutic disasters. Organizational, environmental, and human factors. An IV infusion is a controlled administration of medication into your bloodstream over time.

The two main methods of IV infusion use either gravity. What is a high-risk patient? High level of resource use (e.g., visits, meds, treatments) Frequent visits for urgent or emergent care (e.g., two or more visits in the last six months) Frequent hospitalizations (e.g., two or more in last year) Multiple co-morbidities, including mental health Noncompliance with prescribed treatment/medications.

A total of 1, prescription drugs were identified, averaging ± drugs per prescription. Of these drugs, were intravenous, averaging ± drugs per prescription and ranging from 4 to 15 intravenous drugs per prescription.

At least one incompatibility was found in 68% of the prescriptions analyzed.Medication Safety Recommendations from the Institute Of Medicine Include: Implementing standard process for medication doses, dose timing and dose scale in the patient care areas. Limiting the number of types of common drug administration equipment.

Implementing physician computerized order entry. Have a central pharmacy supply, high risk IV medications.